Sweden· SE-20191230000114
Bupivacaine Noridem 5 mg/ml Injektionsvätska, lösning
A bupivacaine product containing bupivacaine hydrochloride + anhydrous, registered in Sweden by Noridem Enterprises Ltd. The same ATC class is registered in 15 of our 19 countries.
Checked against Swedish Medical Products Agency (Sweden) on
Informational only — not a medical device.
Where it is registered
Bupivacaine is registered in 15 of 19 countries.
Countries holding a registration under ATC N01BB01 (bupivacaine), each read from that country’s own register.
- This record: Sweden, from Swedish Medical Products Agency (Sweden)
- 8 of them publish a price we can compare per daily dose
Bupivacaine · ATC N01BB01
15 / 19 countries
- Belgiumprice
- Canada
- Czechiaprice
- Denmark
- Finlandprice
- Germany
- Icelandprice
- Ireland
- Netherlands
- Norwayprice
- Polandprice
- Sweden
- Switzerlandprice
- United Kingdom
- United Statesprice
The record
At a glance
Swedish Medical Products Agency (Sweden)- Active substance
- Bupivacaine Hydrochloride + Anhydrous
- Manufacturer
- Noridem Enterprises Ltd
- Country
- Sweden (SE)
- ATC code
- N01BB01
- ATC class
- Bupivacaine
- Reimbursed
- Not published by this register
- Source register
- Swedish Medical Products Agency (Sweden)
- Last checked
- October 1, 2026
Packs & prices · 1
- se_varunummer20191230000114
Regulatory notes
No shortage, Orange Book or US label notes for this record.
Interactions
97 interactions on record for bupivacaine.
Graded by severity as the source publishes them — 3 severe. Severity grades are free for everyone; mechanism and management come with Growth.
- Severity for every pair — free, no plan needed
- The source, licence and sync date on every record
- Mechanism and what to do for each pair — Growth plan
Bupivacaine · interactions on record
97 records
- 3 severe
- 31 moderate
- 1 minor
- 62 info
Most severe, free to view
- LidocaineC01BB01severe
- TetracaineN01BA03severe
- LidocaineN01BB02severe
- LidocainA01AE01moderate
- Interaction severity from DDInter 2.0 (Xiong G. et al., Nucleic Acids Res.), licensed CC BY-NC 4.0 — free for non-commercial use only; not covered by the Drug Database commercial licence.
Same class
Other records under N01BB01
Bupivacaine, as other registers publish it.
- United States0.25% BUPIVACAINE HClHF Acquisition Co LLC, DBA HealthFirst
- FinlandBicainOrion Corporation
- FinlandBicainOrion Corporation
- FinlandBicain Pond SpinalOrion Corporation
- FinlandBicain SpinalOrion Corporation
- GermanyBucainEugia Pharma (Malta) Limited
- GermanyBucainEugia Pharma (Malta) Limited
- GermanyBucainEugia Pharma (Malta) Limited
Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of Swedish Medical Products Agency (Sweden). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.
For developers
The same record over the API, and the raw payload
GET /v1/drugs/fa3636c4-8da4-4066-b5a1-5f2953bef432 GET /v1/drugs/fa3636c4-8da4-4066-b5a1-5f2953bef432?format=fhir
Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.
{
"source": "lakemedelsverket",
"doc_types": [
"SmPC",
"PL",
"PAR",
"sPAR"
],
"se_npl_id": "20191230000114",
"product_page": "https://www.lakemedelsverket.se/sv/sok-lakemedelsfakta/lakemedel?id=20191230000114",
"product_doc_link": "https://docetp.mpa.se/LMF/Bupivacaine%20Noridem%20Solution%20for%20injection%20SmPC_09001bee817b69f2.pdf"
}See everything about bupivacaine.
This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.